Albemarle (ALB) PT Lowered to $150.00

Albemarle (NYSE:ALB) had its price objective cut by Jefferies Group to $150.00 in a research note issued to investors on Friday, The Fly reports. They currently have a buy rating on the specialty chemicals company’s stock.

ALB has been the topic of a number of other research reports. Robert W. Baird reiterated a hold rating and set a $135.00 target price on shares of Albemarle in a research report on Wednesday, November 1st. Nomura increased their target price on Albemarle from $146.00 to $154.00 and gave the company a buy rating in a research report on Tuesday, October 10th. Oppenheimer reissued a buy rating on shares of Albemarle in a research note on Wednesday, January 17th. Royal Bank of Canada reissued a buy rating and issued a $149.00 price objective on shares of Albemarle in a research note on Wednesday, October 18th. Finally, Deutsche Bank downgraded Albemarle from a buy rating to a hold rating in a research note on Tuesday, November 14th. Ten equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has an average rating of Buy and an average target price of $127.78.

Albemarle (NYSE:ALB) traded down $2.48 on Friday, hitting $113.53. 3,647,700 shares of the stock traded hands, compared to its average volume of 2,220,436. Albemarle has a 12-month low of $90.35 and a 12-month high of $144.99. The company has a current ratio of 2.11, a quick ratio of 1.56 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $12,600.00, a P/E ratio of 40.55, a P/E/G ratio of 1.52 and a beta of 1.69.

Albemarle (NYSE:ALB) last issued its quarterly earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.07 by $0.01. Albemarle had a net margin of 30.07% and a return on equity of 11.61%. The company had revenue of $755.00 million for the quarter, compared to the consensus estimate of $732.19 million. During the same quarter in the prior year, the company earned $0.91 EPS. Albemarle’s quarterly revenue was up 15.4% on a year-over-year basis. research analysts expect that Albemarle will post 4.46 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, January 2nd. Shareholders of record on Friday, December 15th were paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date was Thursday, December 14th. Albemarle’s dividend payout ratio (DPR) is presently 45.71%.

Institutional investors and hedge funds have recently modified their holdings of the business. Thompson Davis & CO. Inc. increased its stake in shares of Albemarle by 650.0% in the 3rd quarter. Thompson Davis & CO. Inc. now owns 750 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 650 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in shares of Albemarle by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after acquiring an additional 20 shares during the last quarter. Highlander Capital Management LLC acquired a new stake in shares of Albemarle in the 2nd quarter worth $106,000. Howe & Rusling Inc. increased its stake in shares of Albemarle by 2,038.0% in the 3rd quarter. Howe & Rusling Inc. now owns 1,069 shares of the specialty chemicals company’s stock worth $146,000 after acquiring an additional 1,019 shares during the last quarter. Finally, Advisory Services Network LLC increased its stake in shares of Albemarle by 43.7% in the 2nd quarter. Advisory Services Network LLC now owns 1,273 shares of the specialty chemicals company’s stock worth $134,000 after acquiring an additional 387 shares during the last quarter. 87.94% of the stock is owned by institutional investors and hedge funds.

WARNING: “Albemarle (ALB) PT Lowered to $150.00” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://ledgergazette.com/2018/01/23/albemarle-alb-pt-lowered-to-150-00-2.html.

Albemarle Company Profile

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

The Fly

Analyst Recommendations for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply